Literature DB >> 562142

The preferential cytotoxicity of reovirus for certain transformed cell lines.

G Hashiro, P C Loh, J T Yau.   

Abstract

The susceptibility of a variety of cell lines of different mammalian origin to cytotoxic (CT) induction by either ultraviolet light-irradiated reovirus type 2 (UVR2) or viable reovirus type 2 plus the protein synthesis inhibitor, cycloheximide, was examined. The following groups of cells were found to be susceptible to CT-induction: certain tumor cells and spontaneously transformed cell lines of human origin and certain virally and spontaneously transformed cell lines of murine origin. The following groups of cells were found to be resistant: normal human diploid cell lines, primary and continuous cell cultures of subhuman primates, primary mouse cells, normal rat kidney cells and baby hamster kidney cells. Susceptibility to CT-induction could not be related to the adsorption of virus to cells, nor to the capacity of the cell to support virus replication.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 562142     DOI: 10.1007/bf01314776

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  13 in total

1.  The induction of interferon by temperature-sensitive mutants of reovirus, UV-irradiated reovirus, and subviral reovirus particles.

Authors:  M H Lai; W K Joklik
Journal:  Virology       Date:  1973-01       Impact factor: 3.616

2.  Reovirus type 2-infection, cycloheximide, and cell death.

Authors:  P C Loh; J R Crowley
Journal:  Proc Soc Exp Biol Med       Date:  1967 Aug-Sep

3.  RNA polymerase activity in purified reoviruses.

Authors:  A J Shatkin; J D Sipe
Journal:  Proc Natl Acad Sci U S A       Date:  1968-12       Impact factor: 11.205

4.  The preparation of reovirus top component and its effect on host DNA and protein synthesis.

Authors:  M H Lai; J J Wérenne; W K Joklik
Journal:  Virology       Date:  1973-07       Impact factor: 3.616

5.  Early inhibition of cellular DNA synthesis by high multiplicities of infectious and UV-inactivated Reovirus.

Authors:  J E Shaw; D C Cox
Journal:  J Virol       Date:  1973-10       Impact factor: 5.103

6.  Structural proteins of reoviruses.

Authors:  P C Loh; A J Shatkin
Journal:  J Virol       Date:  1968-11       Impact factor: 5.103

7.  Growth characteristics of reovirus type 2: ultraviolet light inactivated virion preparations and cell death.

Authors:  P C Loh; H K Oie
Journal:  Arch Gesamte Virusforsch       Date:  1969

8.  Reovirus: RNA polymerase activity in purified virions.

Authors:  J Borsa; A F Graham
Journal:  Biochem Biophys Res Commun       Date:  1968-12-30       Impact factor: 3.575

9.  Reovirus cytotoxicity: some properties of the UV-irradiated reovirus and its capsid proteins.

Authors:  H A Subasinghe; P C Loh
Journal:  Arch Gesamte Virusforsch       Date:  1972

10.  Accelerated Cytopathology in HeLa Cells Induced by Reovirus and Cycloheximide.

Authors:  P C Loh; H K Oie; R M Ratnayake
Journal:  Infect Immun       Date:  1970-12       Impact factor: 3.441

View more
  44 in total

1.  Reovirus as a novel oncolytic agent.

Authors:  K L Norman; P W Lee
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  REO-10: a phase I study of intravenous reovirus and docetaxel in patients with advanced cancer.

Authors:  Charles Comins; James Spicer; Andrew Protheroe; Victoria Roulstone; Katie Twigger; Christine M White; Richard Vile; Alan Melcher; Matt C Coffey; Karl L Mettinger; Gerard Nuovo; David E Cohn; Mitch Phelps; Kevin J Harrington; Hardev S Pandha
Journal:  Clin Cancer Res       Date:  2010-10-06       Impact factor: 12.531

3.  Differential sensitivity of normal and transformed human cells to reovirus infection.

Authors:  M R Duncan; S M Stanish; D C Cox
Journal:  J Virol       Date:  1978-11       Impact factor: 5.103

4.  Reovirus variants with mutations in genome segments S1 and L2 exhibit enhanced virion infectivity and superior oncolysis.

Authors:  Maya Shmulevitz; Shashi A Gujar; Dae-Gyun Ahn; Adil Mohamed; Patrick W K Lee
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

5.  The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status.

Authors:  M Kim; C T Williamson; J Prudhomme; D G Bebb; K Riabowol; P W K Lee; S P Lees-Miller; Y Mori; M M Rahman; G McFadden; R N Johnston
Journal:  Oncogene       Date:  2010-05-17       Impact factor: 9.867

Review 6.  The sweet spot: defining virus-sialic acid interactions.

Authors:  Jennifer E Stencel-Baerenwald; Kerstin Reiss; Dirk M Reiter; Thilo Stehle; Terence S Dermody
Journal:  Nat Rev Microbiol       Date:  2014-09-29       Impact factor: 60.633

7.  Breast Tumor-Associated Metalloproteases Restrict Reovirus Oncolysis by Cleaving the σ1 Cell Attachment Protein and Can Be Overcome by Mutation of σ1.

Authors:  Jason P Fernandes; Francisca Cristi; Heather E Eaton; Patricia Chen; Sarah Haeflinger; Isabelle Bernard; Mary M Hitt; Maya Shmulevitz
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

Review 8.  Reovirus: a targeted therapeutic--progress and potential.

Authors:  Radhashree Maitra; Mohammad H Ghalib; Sanjay Goel
Journal:  Mol Cancer Res       Date:  2012-10-04       Impact factor: 5.852

9.  Oncolytic reovirus effectively targets breast cancer stem cells.

Authors:  Paola Marcato; Cheryl A Dean; Carman A Giacomantonio; Patrick W K Lee
Journal:  Mol Ther       Date:  2009-03-17       Impact factor: 11.454

10.  The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus.

Authors:  J E Strong; M C Coffey; D Tang; P Sabinin; P W Lee
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.